Allurion Program led to resolution of T2DM, hypertension and OSA after four months
The outcomes from a randomised, double-blind study has demonstrated significant reductions in T2DM, hypertension and obstructive sleep...
top of page
Browse by category
Search
Impact of the Allurion Program on T2DM and prediabetes
New clinical data on the Allurion Program presented at ObesityWeek 2021 has shown that patients had an average haemoglobin A1c reduction...
Allurion Technologies launches new Allurion Weight Loss Program
Allurion Technologies has transformed its Allurion Weight Loss Program and new worldwide brand for the company and its programme....
Browse by tag
bottom of page